Project Grant R21DA058804

Award Date 6/15/24
Completion Date 5/31/26
Dollars Obligated $712K
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
Worcester, MA 01655, USA
Similar Awards
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), is focused on understanding the role of the "need-state" hypothesis in the development of cocaine addiction using an animal model. The $1,447,919 award, spanning May 2025 to February 2030, aims to: Test whether treatment with a GLP-1 receptor agonist can block the aversive conditioned response and subsequent cocaine seeking/taking...
The National Institute on Drug Abuse (NIDA) has awarded a $492,000 Project Grant (CFDA 93.279 - Drug Use and Addiction Research Programs) to the University of Chicago to conduct a multidimensional study on the genetic and epigenetic factors underlying cocaine addiction. The 5-year project aims to: Perform high-resolution chromatin accessibility and DNA methylation profiling to delineate cell-type and circuit-specific epigenetic changes following cocaine self-administration in mice. This will...
This federal Project Grant award of $234,000.00 from the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) supports research at Oregon Health & Science University (OHSU) to investigate the mechanisms underlying cue-induced cocaine craving. The key objectives are to: 1) Use translating ribosome affinity purification and RNA sequencing (TRAP-seq) to identify mRNAs that are actively translating in distinct medium spiny neuron subtypes within the nucleus...
This $1,118,601 Project Grant awarded by the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to investigate the role of orexin neurons in mediating sleep disturbances and drug demand during cocaine abstinence. The research project, conducted by Rutgers, The State University of New Jersey, has three key objectives: 1) Determine if sleep disturbances persist during protracted cocaine abstinence and how they relate to orexin neuron...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $1,996,709.00 to the Trustees of Indiana University (Indiana University Indianapolis) to investigate the role of cortical excitatory projections in cocaine addiction. The 5-year project, which runs from September 30, 2024 to May 31, 2029, aims to examine the excitability of cortical pyramidal neurons in the supplementary motor cortex and...
This $693,129 Project Grant award from the National Institute on Drug Abuse (NIDA) under the federal Drug Use and Addiction Research Programs (CFDA 93.279) supports research to investigate the role of chromatin regulation and brain-derived neurotrophic factor (BDNF) expression in the persistent craving for cocaine after forced abstinence. The primary awardee, Duke University, will use innovative molecular genetic techniques to define the changes in chromatin architecture and gene expression...
The University of Pennsylvania received a $527,837 Project Grant award from the National Institute on Drug Abuse, part of the Department of Health and Human Services, to study altered midbrain GABAergic circuitry and its role in driving greater cocaine self-administration. Specifically, the researchers will characterize the functional state of midbrain GABAergic circuitry and the disposition of the KCC2 potassium-chloride cotransporter during cocaine self-administration, extinction, and...
This five-year, $573,638 project grant from the National Institute on Drug Abuse, part of the Department of Health and Human Services, supports research into the neural mechanisms of individual differences in cocaine avoidance. Funded under the Drug Abuse and Addiction Research Programs (CFDA 93.279), the grant to the Medical University of South Carolina will examine cellular mechanisms by which serotonin and glutamate receptors in the rostromedial tegmental nucleus drive aversive conditioning...
This federal Project Grant award, provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), supports research to characterize the functions of several transcript variants of the DRD3 gene, which encodes the dopamine D3 receptor, and their roles in regulating cocaine-seeking and taking behavior. The $189,644 award to Wake Forest University Health Sciences will fund two phases of research. In the initial R21 phase, the researchers...
This $149,284 Project Grant award from the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) to Vanderbilt University will fund research to understand how chronic cocaine use disrupts the neural processing of aversive, non-drug stimuli in the brain. The study aims to define the precise temporal parameters under which dopamine release modulates the activity of genetically-defined neuron populations in the nucleus accumbens, both at baseline and in...

MESOLIMBIC NOCICEPTIN SIGNALING AND COCAINE REWARD SUPPRESSION - ADDICTION IS A PRESSING PUBLIC HEALTH CONCERN THAT IMPACTS MILLIONS OF PEOPLE IN THE U.S, CAUSING A SIZABLE BURDEN ON THE HEALTH CARE SYSTEM AND THOUSANDS OF UNNECESSARY DEATHS, 1 IN 5 OF WHICH ARE DUE TO PSYCHOSTIMULANT ABUSE, SUCH AS COCAINE. HOWEVER, THE MECHANISMS THAT CONTROL RESPONSE TO COCAINE ARE NOT CLEARLY DEFINED, AND THERE IS A PRESSING NEED TO UNDERSTAND THESE MECHANISMS. THE CURRENT STUDY WILL EXPLORE THE POSSIBILITY THAT THE NEUROPEPTIDE, NOF/Q (AKA: NOCICEPTIN), IS A POTENT COCAINE REWARD SUPPRESSOR THAT ACTS IN MESOLIMBIC TERMINAL REGIONS OF THE NUCLEUS ACCUMBENS (NAC). PRELIMINARY DATA STRONGLY SUPPORT THAT NOF/Q SIGNALING IN NAC BLOCKS COCAINE REWARD, AND THAT NOF/Q CAN ACT DIRECTLY UPON DAERGIC TERMINALS WITHIN NAC. HOWEVER, THE MECHANISMS AND CIRCUITRY THAT MEDIATE NOF/Q REWARD SUPPRESSION IN NAC ARE COMPLETELY UNDEFINED, NOR IS IT KNOWN WHETHER THERE IS BASAL NOF/Q TONE IN NAC THAT CONSTITUTIVELY SETS SENSITIVITY TO REWARDING SUBSTANCES. THE PROPOSED EXPLORATORY STUDIES WILL LEVERAGE A VARIETY OF CUTTING-EDGE VIRAL AND GENETIC TOOLS TO FULLY CHARACTERIZE NOF/Q TONE AND EFFECTS ON REWARD IN NAC, AS WELL AS THE NOF/Q CIRCUITRY INNERVATING NAC AND THAT LIKELY SERVE AS AN ENDOGENOUS REWARD SUPPRESSION SYSTEM. STUDIES IN AIM 1 WILL PROVIDE AN IN-DEPTH ANALYSIS OF COCAINE REWARD SUPPRESSION BY NOF/Q IN MALE AND FEMALE MICE, AND LEVERAGE OPTOGENETICS IN PNOCCRE MICE TO DETERMINE WHETHER ENDOGENOUS NOF/Q SIGNALING IS SUFFICIENT TO SUPPRESS COCAINE REWARD. STUDIES IN AIM 2 WILL LEVERAGE NOPRFL/FL MICE TO TEST WHETHER NOF/Q SIGNALING ON DAERGIC MESOLIMBIC TERMINALS IS REQUIRED FOR COCAINE SUPPRESSION BY NOF/Q. IN ADDITION, AIM 2 STUDIES WILL USE PNOCCRE MICE TO RETROGRADELY TRACE NOF/Q AFFERENTS IN NAC, TO THE LIKELY SOURCE OF ENDOGENOUS NOF/Q. TAKEN TOGETHER, THESE STUDIES WILL PROVIDE A FUNDAMENTAL UNDERSTANDING OF THE POTENTIAL FOR NOF/Q SIGNALING AS POWERFUL SUPPRESSANT OF COCAINE REWARD, AND WILL SHED LIGHT ON AN INTRINSIC MECHANISM THAT SETS REWARD TONE. IMPORTANTLY, THE FINDINGS WILL LAY THE NECESSARY GROUNDWORK FOR FUTURE WORK AIMED AT UNDERSTANDING THE MECHANISMS AND SPECIFIC CIRCUITS THAT MEDIATE NOF/Q REWARD SUPPRESSION.

Posted 6/11/24, 12:00 AM